<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39417399</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>152</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Epidemiology and infection</Title><ISOAbbreviation>Epidemiol Infect</ISOAbbreviation></Journal><ArticleTitle>The spatial-temporal variations and influencing factors of COVID-19 case fatality rate: a worldwide study in 30 countries from February 2021 to May 2022.</ArticleTitle><Pagination><StartPage>e124</StartPage><MedlinePgn>e124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e124</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268824000852</ELocationID><Abstract><AbstractText>To evaluate the variations in COVID-19 case fatality rates (CFRs) across different regions and waves, and the impact of public health interventions, social and economic characteristics, and demographic factors on COVID-19 CFRs, we collected data from 30 countries with the highest incidence rate in three waves. We summarized the CFRs of different countries and continents in each wave through meta-analysis. Spearman's correlation and multiple linear regression were employed to estimate the correlation between influencing factors and reduction rates of CFRs. Significant differences in CFRs were observed among different regions during the three waves (<i>P</i> &lt; 0.001). An association was found between the changes in fully vaccinated rates (<i>r</i> <sub><i>s</i></sub>  = 0.41), population density (<i>r</i> <sub><i>s</i></sub>  = 0.43), the proportion of individuals over 65 years old (<i>r</i> <sub><i>s</i></sub>  = 0.43), and the reduction rates of case fatality rate. Compared to Wave 1, the reduction rates in Wave 2 were associated with population density (<i>β</i> = 0.19, 95%<i>CI</i>: 0.05-0.33) and smoking rates (<i>β</i> = -4.66, 95%<i>CI</i>: -8.98 - -0.33), while in Wave 3 it was associated with booster vaccine rates (<i>β</i> = 0.60, 95%<i>CI</i>: 0.11-1.09) and hospital beds per thousand people (<i>β</i> = 4.15, 95%<i>CI</i>: 1.41-6.89). These findings suggest that the COVID-19 CFRs varied across different countries and waves, and promoting booster vaccinations, increasing hospital bed capacity, and implementing tobacco control measures can help reduce CFRs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xing</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0003-7122-8555</Identifier><AffiliationInfo><Affiliation>School of Public Health, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Zuhua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Ruiqi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jianpeng</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9665-6036</Identifier><AffiliationInfo><Affiliation>School of Public Health, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Guoqing</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No. 512808</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Infect</MedlineTA><NlmUniqueID>8703737</NlmUniqueID><ISSNLinking>0950-2688</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062211" MajorTopicYN="N">Spatio-Temporal Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">case fatality rate</Keyword><Keyword MajorTopicYN="N">influencing factors</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">public health interventions</Keyword><Keyword MajorTopicYN="N">spatial–temporal changes</Keyword></KeywordList><CoiStatement>The authors declare none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>16</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39417399</ArticleId><ArticleId IdType="pmc">PMC11502459</ArticleId><ArticleId IdType="doi">10.1017/S0950268824000852</ArticleId><ArticleId IdType="pii">S0950268824000852</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Williams BA, et al. (2023) Outlook of pandemic preparedness in a post-COVID-19 world. Npj Vaccines 8, 178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10662147</ArticleId><ArticleId IdType="pubmed">37985781</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shabasy RM, et al. (2022) Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic. International Journal of Biological Macromolecules. 204, 161–168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8782737</ArticleId><ArticleId IdType="pubmed">35074332</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorci G, et al. (2020) Explaining among-country variation in COVID-19 case fatality rate. Scientific Reports 10, 18909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7609641</ArticleId><ArticleId IdType="pubmed">33144595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampl B, et al. (2023) COVID-19-related deaths: A 2-year inter-wave comparison of mortality data from Germany. Infection 51, 1147–1152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9870770</ArticleId><ArticleId IdType="pubmed">36690889</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian D, et al. (2022) The global epidemic of SARS-CoV-2 variants and their mutational immune escape. Journal of Medical Virology 94, 847–857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661756</ArticleId><ArticleId IdType="pubmed">34609003</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue L, et al. (2022) Infectivity versus fatality of SARS-CoV-2 mutations and influenza. International Journal of Infectious Diseases 121, 195–202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9107628</ArticleId><ArticleId IdType="pubmed">35584743</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghadas SM, et al. (2021) The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States. Clinical Infectious Diseases 73, 2257–2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929033</ArticleId><ArticleId IdType="pubmed">33515252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ergönül Ö, et al. (2021) National case fatality rates of the COVID-19 pandemic. Clinical Microbiology and Infection 27, 118–124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510430</ArticleId><ArticleId IdType="pubmed">32979575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandula S and Shaman J (2021) Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: A modeling study. Plos Medicine 18, e1003693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8277036</ArticleId><ArticleId IdType="pubmed">34255766</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowd JB, et al. (2020) Demographic science aids in understanding the spread and fatality rates of COVID-19. Proceedings of the National Academy of Sciences of the United States of America 117, 9696–9698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211934</ArticleId><ArticleId IdType="pubmed">32300018</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahamat-Saleh Y, et al. (2021) Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: A systematic review and meta-analysis of observational studies. BMJ Open 11, e52777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8557249</ArticleId><ArticleId IdType="pubmed">34697120</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift AK, et al. (2022) Smoking and COVID-19 outcomes: An observational and Mendelian randomisation study using the UK biobank cohort. Thorax 77, 65–73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8483921</ArticleId><ArticleId IdType="pubmed">34580193</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauring AS, et al. (2022) Clinical severity of and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: Prospective observational study. BMJ 376, e69761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905308</ArticleId><ArticleId IdType="pubmed">35264324</ArticleId></ArticleIdList></Reference><Reference><Citation>Our World in Data The data on the coronavirus pandemic, 19 March 2020. Available at https://ourworldindata.org/coronavirus (accessed 3 August 2022).</Citation></Reference><Reference><Citation>Jin R (2021) The lag between daily reported Covid-19 cases and deaths and its relationship to age. Journal of Public Health Research 10, 2049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8431868</ArticleId><ArticleId IdType="pubmed">33709641</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Hiyoshi A and Montgomery S (2020) COVID-19 case-fatality rate and demographic and socioeconomic influencers: Worldwide spatial regression analysis based on country-level data. BMJ Open 10, e43560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640588</ArticleId><ArticleId IdType="pubmed">33148769</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehm E, et al. (2021) Novel SARS-CoV-2 variants: The pandemics within the pandemic. Clinical Microbiology and Infection 27, 1109–1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8127517</ArticleId><ArticleId IdType="pubmed">34015535</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, et al. (2021) Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology 19, 141–154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2023) Ending the COVID-19 emergency and transitioning from emergency phase to longer-term disease management: Guidance on calibrating the response. Available at https://www.who.int/publications/i/item/WHO-WHE-SPP-2023.2 (accessed 23 November 2023).</Citation></Reference><Reference><Citation>Hsu SH, et al. (2021) Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada. International Journal of Infectious Diseases 109, 189–191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245301</ArticleId><ArticleId IdType="pubmed">34216734</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan G, et al. (2021) Decreased case fatality rate of COVID-19 in the second wave: A study in 53 countries or regions. Transboundary and Emerging Diseases 68, 213–215.</Citation><ArticleIdList><ArticleId IdType="pubmed">32892500</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrenn JO, et al. (2022) COVID-19 severity from omicron and Delta SARS-CoV-2 variants. Influenza and Other Respiratory Viruses 16, 832–836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111734</ArticleId><ArticleId IdType="pubmed">35415869</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenchula S, et al. (2022) Current evidence on efficacy of COVID-19 booster dose vaccination against the omicron variant: A systematic review. Journal of Medical Virology 94, 2969–2976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088621</ArticleId><ArticleId IdType="pubmed">35246846</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiuzzi C and Lippi G (2022) Primary COVID-19 vaccine cycle and booster doses efficacy: Analysis of Italian nationwide vaccination campaign. European Journal of Public Health 32, 328–330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755380</ArticleId><ArticleId IdType="pubmed">34978571</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif N, et al. (2021) Impact of meteorological parameters and population density on variants of SARS-CoV-2 and outcome of COVID-19 pandemic in Japan. Epidemiology and Infection 149, e103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134905</ArticleId><ArticleId IdType="pubmed">33908339</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadu I, et al. (2021) Assessing sub-regional-specific strengths of healthcare systems associated with COVID-19 prevalence, deaths and recoveries in Africa. PLoS One 16, e247274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7920381</ArticleId><ArticleId IdType="pubmed">33647032</ArticleId></ArticleIdList></Reference><Reference><Citation>Safiabadi TS, et al. (2021) Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clinical Microbiology Reviews 34, e00228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142517</ArticleId><ArticleId IdType="pubmed">33980687</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M, et al. (2022) Association between smoking, e-cigarette use and severe COVID-19: A cohort study. International Journal of Epidemiology 51, 1062–1072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903448</ArticleId><ArticleId IdType="pubmed">35179598</ArticleId></ArticleIdList></Reference><Reference><Citation>Niforatos JD, Melnick ER and Faust JS (2020) Covid-19 fatality is likely overestimated. BMJ 368, m1113.</Citation><ArticleIdList><ArticleId IdType="pubmed">32198267</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, et al. (2022) Effects of vaccination and non-pharmaceutical interventions and their lag times on the COVID-19 pandemic: Comparison of eight countries. PLoS Neglected Tropical Diseases 16, e10101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757886</ArticleId><ArticleId IdType="pubmed">35025865</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>